Zogenix, Inc. Prices $200.0 Million Convertible Senior Notes Offering

EMERYVILLE, Calif., Sept. 23, 2020 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq: ZGNX) today announced the pricing of its offering of $200,000,000 aggregate principal amount of 2.75% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The issuance and sale of the notes are scheduled to settle on September 28, 2020, subject to customary closing conditions. Zogenix also granted the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date notes are first issued, up to an additional $30,000,000 principal amount of notes.

The notes will be senior, unsecured obligations of Zogenix and will accrue interest at a rate of 2.75% per annum, payable semi-annually in arrears on April 1 and October 1 of each year, beginning on

Read More

Read More

Biotech start-up Chimeric closes convertible note raising

Cancer-fighting drug developer Chimeric Therapeutics has got some fresh capital in the door as it advances a clinical trial on its brain cancer therapy.

Cancer-fighting drug developer Chimeric Therapeutics has closed a convertible note fundraising round. Erin Jonasson

Street Talk understands Chimeric has closed a $4.3 million convertible note seed fundraising round, overseen by broker Baker Young.

The company was founded and is chaired by Aussie biotech entrepreneur Paul Hopper, who sits on the boards of ASX-listed biotech outfits Imugene and Suda Pharmaceuticals.

Its primary focus is on developing its CLTX CAR-T asset, which uses a peptide to target brain cancer and is being developed out of Los Angeles at the City of Hope cancer research centre.

Chimeric chairman Hopper was the former chairman of Viralytics, which was bought by US pharma multinational Merck in 2018 for $502 million.

News of the raising comes as Chimeric kicks off a phase

Read More

Read More

SolarEdge Technologies, Inc. Announces Pricing of Private Offering of $550 Million of 0.00% Convertible Senior Notes due 2025

FREMONT, Calif.–(BUSINESS WIRE)–Sep 23, 2020–

SolarEdge Technologies, Inc. (Nasdaq: SEDG) (“SolarEdge”) today announced the pricing of $550 million aggregate principal amount of 0.00% Convertible Senior Notes due 2025 (the “Notes”) in a private offering (the “Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the Offering, SolarEdge has granted the initial purchasers of the Notes a 13-day option to purchase up to an additional $82.5 million aggregate principal amount of the Notes on the same terms and conditions. The sale of the Notes to the initial purchasers is expected to settle on September 25, 2020, subject to customary closing conditions.

The Notes will not bear regular interest. The Notes will mature on September 15, 2025, unless earlier repurchased or converted in accordance with their terms prior to such date. The Notes

Read More

Read More

Sproutly Amends Maturity Date and Conversion Price of Convertible Debentures

VANCOUVER, British Columbia–(BUSINESS WIRE)–Sep 23, 2020–

Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF) (FSE: 38G) (“ Sproutly ” or the “ Company ”) announces that the Company has entered into a third supplemental indenture dated September 23, 2020 (the “ Third Supplemental Indenture ”) between the Company and TSX Trust Company, as trustee, which amends the terms of its convertible debenture indenture dated October 24, 2018 (the “ Original Indenture ”), as amended by the first supplemental indenture dated April 24, 2020 (the “ First Supplemental Indenture ”) and as further amended by the second supplemental indenture dated July 23, 2020 (the “Second Supplemental Indenture”, and together with the Original Indenture and the Third Supplemental Indenture, the “ Indenture ”) providing for the issue of 8.0% senior unsecured convertible debentures in the aggregate principal amount of up to $10,750,000 (the “ Debentures ”).

Pursuant to the Third Supplemental Indenture,

Read More

Read More

How Sofia Coppola shot her Fast & Furious fantasy with Bill Murray in a convertible

Around the Table with ‘The Virgin Suicides’

The cast and director of The Virgin Suicides discuss the making of the film.

If, from inside the warm confines of a darkened megaplex playing the latest Fast & Furious sequel, you’ve ever leaned over to your best dudefriend during a wild chase scene and gently whispered, “Bro, I would like to see Sofia Coppola do this someday,” On the Rocks has just the scene for you!

Around halfway through her new comedy, the writer-director does something she’s never attempted before, and flexes her inner Michael Bay muscles (well, not quite, but you get the idea) over a scene that sees stars Bill Murray and Rashida Jones careening through the streets of New York City in a red vintage Alfa Romeo convertible. It’s a remarkably kinetic scene for a director best known for telling poignant stories through silent gestures, and Coppola tells

Read More

Read More

Omnicell Floating $500 Million Convertible Notes Issue

Omnicell (NASDAQ:OMCL) is hoping to reap at least $500 million from an upcoming round of capital raising. The company, which specializes in automation solutions for the pharmaceutical industry, is floating an issue of unsecured, convertible senior notes at that aggregate principal amount. They will be sold in a private placement to qualified institutional buyers. The timing of the issue has not been set.

The notes mature in 2025, and will pay interest semi-annually; the rate will be determined when the issue is priced. They will be convertible either to shares of Omnicell common stock, cash, or a combination of the two. As with the interest, the conversion rates have not yet been set.

Stethoscope atop 100 dollar bills and pennies.

Image source: Getty Images.

The company added that it plans to offer the initial purchasers of the notes an option to buy up to $75 million more of the notes in aggregate principal amount. This option will

Read More

Read More

Teligent Announces Completion of Series D Convertible Note Exchange

BUENA, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) — Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the
closing of the issuance of approximately $27.5 million aggregate principal amount of Zero Coupon Convertible Senior Notes due 2023 (the “New 2023 Notes”) in exchange for approximately $57.9 million
in aggregate principal amount, plus accrued but unpaid interest, of the Company’s outstanding 4.75% Convertible Senior Notes due May 2023 (the “Series A Convertible Notes”), which gives effect to a
52.5% discount on the principal amount of Series A Convertible Notes exchanged. The Company also issued approximately $0.4 million aggregate principal amount of New 2023 Notes in exchange for
approximately $0.5 million in aggregate principal amount, plus accrued but unpaid interest, of the Company’s outstanding 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible Notes due 2023
(the “Series B Convertible Notes”), which gives effect

Read More

Read More

SolarEdge Technologies, Inc. Announces Pricing of Private Offering of $550 Million of 0.00% Convertible Senior Notes due 2025 – Press Release

FREMONT, Calif.–(Business Wire)–SolarEdge Technologies, Inc. (Nasdaq: SEDG) (“SolarEdge”) today announced the pricing of $550 million aggregate principal amount of 0.00% Convertible Senior Notes due 2025 (the “Notes”) in a private offering (the “Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the Offering, SolarEdge has granted the initial purchasers of the Notes a 13-day option to purchase up to an additional $82.5 million aggregate principal amount of the Notes on the same terms and conditions. The sale of the Notes to the initial purchasers is expected to settle on September 25, 2020, subject to customary closing conditions.

The Notes will not bear regular interest. The Notes will mature on September 15, 2025, unless earlier repurchased or converted in accordance with their terms prior to such date. The Notes will not be

Read More

Read More

Omnicell, Inc. Prices $500 Million 0.25% Convertible Senior Notes Offering (up 37.5% Conversion Premium)

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced today the pricing of $500 million aggregate principal amount of 0.25% Convertible Senior Notes due 2025 (the “notes”) in a private placement (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).

Key elements of the transaction include:

  • $500 million 0.25% Convertible Senior Notes Offering (up 37.5% Conversion Premium)

  • Convertible note hedge transactions and warrant transactions entered into in connection with the 0.25% Convertible Senior Notes due 2025 with a strike price for the warrant transactions initially equal $141.56 per share, which represents a 100% premium to the closing sale price of Omnicell’s common stock on September 22, 2020

  • Repurchase of approximately $53.0 million of common stock

Omnicell has also granted the initial purchasers of the notes an option

Read More

Read More

DSG Global Pays Off all Active Convertible Notes in Preparation for Growth and Market Expansion and to Avoid Further Equity Dilution

The MarketWatch News Department was not involved in the creation of this content.

Surrey, British Columbia, Canada, Sep 22, 2020 (GLOBE NEWSWIRE via COMTEX) —
Surrey, British Columbia, Canada, Sept. 22, 2020 (GLOBE NEWSWIRE) — DSG Global Inc. (OTCQB: DSGT) (“DSGT”), a technology development company engaged in the design, manufacture, sales and leasing of GPS tracking devices, interfaces for golf and electric vehicles and related support services is pleased to announce that it has repaid and satisfied existing convertible notes that had become due and convertible into common stock at a significant discount to market. As a result of the full payment of the Notes, the Notes are no longer a debt obligation of the Company and, as such, are no longer convertible into shares of the Company’s common stock.

“Eliminating these convertible notes represents a significant milestone for DSG Global as now for the first time in two years

Read More

Read More

1 2 3 12